Hydroxylation of lansoprazole in poor metabolizers of CYP2C19
Open Access
- 1 December 2005
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 61 (3), 361
- https://doi.org/10.1111/j.1365-2125.2005.02551.x
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Effects of clarithromycin on lansoprazole pharmacokinetics betweenCYP2C19genotypesBritish Journal of Clinical Pharmacology, 2005
- Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans*Clinical Pharmacology & Therapeutics, 1999